skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 170  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove subject: Care And Treatment remove subject: Risk Factors remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years
Material Type:
Article 		Add to My Research

Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years

BMC cancer, 2022-07, Vol.22 (1), p.1-836, Article 836 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09940-3 ;PMID: 35907848

Full text available

Citations Cited by
2
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
Material Type:
Article 		Add to My Research

PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer

BMC cancer, 2015-08, Vol.15 (1), p.602, Article 602 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Owadally et al. 2015 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-015-1598-x ;PMID: 26311526

Full text available

Citations Cited by
3
Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting
Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting
Material Type:
Article 		Add to My Research

Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting

BMC cancer, 2022-03, Vol.22 (1), p.275-275, Article 275 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09317-6 ;PMID: 35291972

Full text available

Citations Cited by
4
A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma
A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma
Material Type:
Article 		Add to My Research

A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma

BMC cancer, 2022-03, Vol.22 (1), p.264-264, Article 264 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09322-9 ;PMID: 35279104

Full text available

Citations Cited by
5
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

BMC cancer, 2022-03, Vol.22 (1), p.270-270, Article 270 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09325-6 ;PMID: 35287627

Full text available

Citations Cited by
6
A nomogram prediction model for lymph node metastasis in endometrial cancer patients
A nomogram prediction model for lymph node metastasis in endometrial cancer patients
Material Type:
Article 		Add to My Research

A nomogram prediction model for lymph node metastasis in endometrial cancer patients

BMC cancer, 2021-06, Vol.21 (1), p.1-748, Article 748 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08466-4 ;PMID: 34187416

Full text available

Citations Cited by
7
Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection
Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection
Material Type:
Article 		Add to My Research

Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection

BMC cancer, 2022-06, Vol.22 (1), p.1-664, Article 664 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09743-6 ;PMID: 35715783

Full text available

Citations Cited by
8
INHBA is a prognostic predictor for patients with colon adenocarcinoma
INHBA is a prognostic predictor for patients with colon adenocarcinoma
Material Type:
Article 		Add to My Research

INHBA is a prognostic predictor for patients with colon adenocarcinoma

BMC cancer, 2020-04, Vol.20 (1), p.305-305, Article 305 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06743-2 ;PMID: 32293338

Full text available

Citations Cited by
9
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment
Material Type:
Article 		Add to My Research

Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment

BMC cancer, 2022-04, Vol.22 (1), p.368-368, Article 368 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09439-x ;PMID: 35392843

Full text available

Citations Cited by
10
Identification of a pyroptosis-related prognostic signature in breast cancer
Identification of a pyroptosis-related prognostic signature in breast cancer
Material Type:
Article 		Add to My Research

Identification of a pyroptosis-related prognostic signature in breast cancer

BMC cancer, 2022-04, Vol.22 (1), p.429-429, Article 429 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09526-z ;PMID: 35443644

Full text available

Citations Cited by
11
Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data
Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data
Material Type:
Article 		Add to My Research

Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data

BMC cancer, 2023-11, Vol.23 (1), p.1-1147, Article 1147 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11628-1

Full text available

Citations Cited by
12
Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy
Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy
Material Type:
Article 		Add to My Research

Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy

BMC cancer, 2023-11, Vol.23 (1), p.1-1116, Article 1116 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11621-8

Full text available

Citations Cited by
13
The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer
The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer
Material Type:
Article 		Add to My Research

The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer

BMC cancer, 2023-10, Vol.23 (1), p.1-1018, Article 1018 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11523-9

Full text available

Citations Cited by
14
Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma
Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma

BMC cancer, 2023-01, Vol.23 (1), p.25-25, Article 25 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10461-2 ;PMID: 36611155

Full text available

Citations Cited by
15
Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis
Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis

BMC cancer, 2023-10, Vol.23 (1), p.1-933, Article 933 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11424-x ;PMID: 37789268

Full text available

Citations Cited by
16
Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis
Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis

BMC cancer, 2023-07, Vol.23 (1), p.644-644, Article 644 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11049-0 ;PMID: 37430191

Full text available

Citations Cited by
17
Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma
Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma

BMC cancer, 2022-04, Vol.22 (1), p.431-431, Article 431 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09530-3 ;PMID: 35443674

Full text available

Citations Cited by
18
Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer
Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer
Material Type:
Article 		Add to My Research

Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer

BMC cancer, 2023-06, Vol.23 (1), p.576-576, Article 576 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11083-y ;PMID: 37349711

Full text available

Citations Cited by
19
Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms
Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms
Material Type:
Article 		Add to My Research

Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms

BMC cancer, 2019-06, Vol.19 (1), p.604-604, Article 604 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5814-y ;PMID: 31216997

Full text available

Citations Cited by
20
Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis
Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis
Material Type:
Article 		Add to My Research

Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis

BMC cancer, 2021-05, Vol.21 (1), p.513-513, Article 513 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08253-1 ;PMID: 33962555

Full text available

Citations Cited by

Results 1 - 20 of 170  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2013  (9)
  2. 2013 To 2016  (22)
  3. 2017 To 2018  (5)
  4. 2019 To 2021  (59)
  5. After 2021  (76)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait